Develops and markets medical devices for minimally invasive surgery and therapeutic ultrasound.
EDAP TMS S.A., headquartered in Lyon, France, operates globally with a focus on developing, manufacturing, and distributing minimally invasive medical devices tailored for treating urological diseases. The company's comprehensive portfolio encompasses three key segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). In the HIFU segment, EDAP TMS specializes in ultrasound-guided robotic devices like Ablatherm, designed for treating organ-confined prostate cancer, and Ablatherm Fusion, which integrates proprietary fusion software merging MRI and ultrasound images. The company also offers Focal One, a dedicated HIFU robotic device for focal therapy in prostate cancer, along with disposables, leasing options, and related treatment services.
The ESWL division focuses on manufacturing and servicing lithotripters, such as the Sonolith i-move, utilized in the non-invasive treatment of urinary tract stones through Extracorporeal ShockWave Lithotripsy technology. Additionally, EDAP TMS provides disposable parts for lithotripters and electrodes, ensuring comprehensive support to small and mid-size hospitals globally. The Distribution segment markets and distributes lasers, micro-ultrasound systems, and other medical products from third-party manufacturers, complemented by leasing options, disposables, spare parts, and maintenance services. This divizion enhances the company's market presence and customer base, serving hospitals, urology clinics, and research institutions worldwide.
Founded in 1979, EDAP TMS S.A. has established itself as a leader in the urological medical device sector, leveraging advanced technologies to provide effective, minimally invasive solutions. With a robust network of direct sales, distributors, and agents, the company coontinues to expand its global reach, aiming to enhance patient outcomes and support healthcare providers in delivering optimal urological care.